FI783709A7 - Pleuromutilinglykosidderivat - Google Patents

Pleuromutilinglykosidderivat Download PDF

Info

Publication number
FI783709A7
FI783709A7 FI783709A FI783709A FI783709A7 FI 783709 A7 FI783709 A7 FI 783709A7 FI 783709 A FI783709 A FI 783709A FI 783709 A FI783709 A FI 783709A FI 783709 A7 FI783709 A7 FI 783709A7
Authority
FI
Finland
Prior art keywords
pleuromutiling
glycoside derivatives
glycoside
derivatives
pleuromutiling glycoside
Prior art date
Application number
FI783709A
Other languages
English (en)
Finnish (fi)
Inventor
Ramakrishnan Nagarajan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI783709A7 publication Critical patent/FI783709A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI783709A 1977-12-08 1978-12-04 Pleuromutilinglykosidderivat FI783709A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/858,507 US4130709A (en) 1977-12-08 1977-12-08 Pleuromutilin glycoside derivatives

Publications (1)

Publication Number Publication Date
FI783709A7 true FI783709A7 (fi) 1979-06-09

Family

ID=25328471

Family Applications (1)

Application Number Title Priority Date Filing Date
FI783709A FI783709A7 (fi) 1977-12-08 1978-12-04 Pleuromutilinglykosidderivat

Country Status (28)

Country Link
US (1) US4130709A (cs)
EP (1) EP0002588B1 (cs)
JP (1) JPS5498751A (cs)
AT (1) AT362065B (cs)
AU (1) AU524665B2 (cs)
BE (1) BE872489A (cs)
CA (1) CA1109866A (cs)
CH (1) CH639103A5 (cs)
CS (2) CS219342B2 (cs)
DD (1) DD139858A5 (cs)
DE (1) DE2862226D1 (cs)
DK (1) DK539578A (cs)
ES (1) ES475854A1 (cs)
FI (1) FI783709A7 (cs)
FR (1) FR2411205A1 (cs)
GB (1) GB2009738B (cs)
GR (1) GR72774B (cs)
HU (1) HU181429B (cs)
IE (1) IE47533B1 (cs)
IL (1) IL56115A (cs)
IT (1) IT1160316B (cs)
LU (1) LU80619A1 (cs)
PL (1) PL123850B1 (cs)
PT (1) PT68857A (cs)
RO (3) RO80082A (cs)
SU (1) SU902666A3 (cs)
YU (1) YU281878A (cs)
ZA (1) ZA786872B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5594359A (en) * 1979-01-12 1980-07-17 Sandoz Ag Novel pleuromutilin derivatives*their manufacture and use
US5041534A (en) * 1983-03-22 1991-08-20 Merrell Dow Pharmaceuticals Process for preparing antibiotic L 17054
FR2551442B1 (fr) * 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
US5077398A (en) * 1986-11-18 1991-12-31 Merck & Co., Inc. Process for isolation of avermectin B1 components with improved purity and subsequent isolaton of B2 components
US5696096A (en) * 1990-09-28 1997-12-09 Bristol-Myers Squibb Company Pradimicin derivatives
US5843908A (en) * 1990-09-28 1998-12-01 Bristol-Myers Squibb Company Pradimicins l and fl, and derivatives thereof
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
JP3816570B2 (ja) * 1996-02-16 2006-08-30 塩水港精糖株式会社 アシル化剤
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
ES2182703B1 (es) * 2001-06-18 2004-06-01 Consejo Superior De Investigaciones Cientificas Un procedimiento enzimatico para obtener 4-0-b-d-galactopiranosil-d-xilosa, 4-o-b-d-galactopiranosil-d-xilosa obtenida de acuerdo con el pr cedimiento, composiciones que la contienen y su uso en la evaluacion de la lactasa intestinal.
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
US7875630B2 (en) 2003-09-03 2011-01-25 Glaxo Group Limited Process salts compositions and use
US6838576B1 (en) 2003-10-23 2005-01-04 3M Innovative Properties Company Process for preparing functional group-containing olefinic compounds
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
US7998927B2 (en) * 2006-06-23 2011-08-16 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US8173594B2 (en) * 2006-06-23 2012-05-08 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US8084022B2 (en) 2006-06-23 2011-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US8226949B2 (en) * 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
US20090326193A1 (en) * 2006-06-23 2009-12-31 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
EP1972618A1 (en) * 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
ES2586032T3 (es) 2008-03-28 2016-10-11 Hale Biopharma Ventures, Llc Administración de composiciones de benzodiazepinas
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
DK2720699T3 (en) 2011-06-14 2018-08-20 Hale Biopharma Ventures Llc ADMINISTRATION OF BENZODIAZEPINE
CA2961672A1 (en) * 2014-09-19 2016-03-24 Emory University Saccharide analogs and agents for the diagnosis and therapy of bacterial infections
SI3310331T1 (sl) 2015-06-17 2021-02-26 Nabriva Therapeutics GmbH Farmacevtska formulacija lefamulina, ki se jo da injicirati

Also Published As

Publication number Publication date
GB2009738B (en) 1982-11-10
CS219342B2 (en) 1983-03-25
JPS5498751A (en) 1979-08-03
CH639103A5 (fr) 1983-10-31
RO84425B (ro) 1984-08-30
EP0002588A1 (en) 1979-06-27
RO84425A (ro) 1984-06-21
AU524665B2 (en) 1982-09-30
US4130709A (en) 1978-12-19
RO80082B (ro) 1983-01-30
ZA786872B (en) 1980-08-27
ATA871578A (de) 1980-09-15
GB2009738A (en) 1979-06-20
RO80082A (ro) 1983-02-01
DE2862226D1 (en) 1983-05-11
GR72774B (cs) 1983-12-05
HU181429B (en) 1983-07-28
LU80619A1 (fr) 1979-06-05
IE47533B1 (en) 1984-04-18
AT362065B (de) 1981-04-27
AU4216278A (en) 1979-06-14
RO84426A (ro) 1984-06-21
IE782421L (en) 1979-06-08
IL56115A0 (en) 1979-03-12
FR2411205A1 (fr) 1979-07-06
CA1109866A (en) 1981-09-29
IT1160316B (it) 1987-03-11
YU281878A (en) 1983-06-30
ES475854A1 (es) 1980-05-16
CS219344B2 (en) 1983-03-25
BE872489A (fr) 1979-06-05
EP0002588B1 (en) 1983-04-06
SU902666A3 (ru) 1982-01-30
PL123850B1 (en) 1982-12-31
DD139858A5 (de) 1980-01-23
DK539578A (da) 1979-07-05
RO84426B (ro) 1984-08-30
PL211492A1 (pl) 1979-11-19
IT7830657A0 (it) 1978-12-06
FR2411205B1 (cs) 1981-08-14
IL56115A (en) 1984-01-31
PT68857A (en) 1979-01-01

Similar Documents

Publication Publication Date Title
FI783709A7 (fi) Pleuromutilinglykosidderivat
SE7805879L (sv) Mevalonolaktonderivat
DK370778A (da) Triphenylakenderivater
BE867269A (fr) Derives de thiopropanoylamino-acides
SE7803057L (sv) Bensimidazolderivat
SE7711581L (sv) Xantin-derivat
DK543178A (da) Thiodydantoinderivater
SE7804446L (sv) Tienamycinderivat
IT1104845B (it) Antibiotico n-acetil-deidro-tienamicina
SE7801997L (sv) Dipeptidderivat
SE7805260L (sv) Alkylendiaminderivat
SE7800982L (sv) Meta-sulfonamido-bensamid-derivat
SE7805140L (sv) Bensimidazolderivat
BE873217A (fr) Antibiotique g-6302
FI783393A7 (fi) 2-imino-imidazolidinderivat
SE7801312L (sv) Oxadiazolopyrimidin-derivat
DK191678A (da) Anthracyklinderivat
FI780343A7 (fi) Oxadiazolopyrimidinderivat
DK292678A (da) Benzofuranderivater
SE7803418L (sv) Kinazolinderivat
BR7808456A (pt) Novos derivados de pirazina
SE7800033L (sv) Kromonderivat
MC1195A1 (fr) Derives acyles
DK192678A (da) Paavirkningsenhed
FI780402A7 (fi) Foerfarande foer framstaellning av bensoheterocyklylglyoxylsyraderivat